Five years of experience and observation with therapy of maintenance with very low dose thalidomide after auto-SCT in multiple myeloma

被引:0
作者
Pezzullo, L. [1 ]
Rocco, S. [1 ]
Bene, L. [1 ]
Ferrara, M. G. [1 ]
Finizio, O. [1 ]
Nunziata, G. [1 ]
Martorelli, C. [1 ]
Mettivier, L. [1 ]
Buonanno, M. T. [1 ]
Mettivier, V [1 ]
机构
[1] Cardarelli Hosp, Hematol Div A, Naples, Italy
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:146 / 147
页数:2
相关论文
共 50 条
[41]   Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation [J].
Aznab, Mozaffar ;
Rezaei, Mansour ;
Navabi, Jafar ;
Moieni, Ali .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (02) :E138-E143
[42]   Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma [J].
Murakami, Hirokazu ;
Handa, Hiroshi ;
Abe, Masahiro ;
Iida, Sinsuke ;
Ishii, Akihiro ;
Ishikawa, Takayuki ;
Ishida, Tadao ;
Oota, Masatsugu ;
Ozaki, Shuji ;
Kosaka, Masaaki ;
Sakai, Akira ;
Sawamura, Morio ;
Shimazaki, Chihiro ;
Shimizu, Kazuyuki ;
Takagi, Toshiyuki ;
Hata, Hiroyuki ;
Fukuhara, Takashi ;
Fujii, Hiroshi ;
Miyata, Akira ;
Wakayama, Toshio ;
Takatsuki, Kiyoshi .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) :234-239
[43]   Single high-dose chemoradiotherapy versus tandem high dose melphalan followed by Auto-SCT for advanced multiple myeloma. Preliminary analysissis. [J].
Einsele, H ;
Liebisch, P ;
Bargou, R ;
Meisner, C ;
Metzner, B ;
Wandt, H ;
Wolf, HH ;
Sezer, O ;
Casper, J ;
Pfreundschuh, M ;
Maschmeyer, G ;
Straka, C ;
Truemper, L ;
Kroeger, N ;
Mueller, P ;
Hertenstein, B ;
Frickhofen, N ;
Coser, P ;
Bamberg, M ;
Hebart, H ;
Kanz, L .
BLOOD, 2004, 104 (11) :156A-156A
[44]   Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study [J].
Feyler, Sylvia ;
Rawstron, Andy ;
Jackson, Graham ;
Snowden, John A. ;
Cocks, Kim ;
Johnson, Roderick J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) :429-433
[45]   Thalidomide maintenance following high dose therapy in multiple myeloma: A UK myeloma forum phase 2 study. [J].
Feyler, S ;
Jackson, G ;
Rawstron, A ;
El-Sherbiny, YM ;
Snowden, JA ;
Johnson, RJ .
BLOOD, 2003, 102 (11) :691A-691A
[46]   Thalidomide maintenance following high dose therapy in multiple myeloma: A UK myeloma forum phase 2 study. [J].
Feyler, S ;
Rawstron, A ;
Jackson, G ;
Snowden, J ;
Hawkins, K ;
Johnson, RJ .
BLOOD, 2005, 106 (11) :190A-190A
[47]   Thalidomide (THAL) as salvage therapy for relapsed multiple myeloma (MM) after allogeneic stem cell transplantation (SCT). [J].
Yakoub-agha, I ;
Mohty, M ;
Attal, M ;
Marit, G ;
Bulabois, CE ;
Sotto, JJ ;
Gratecos, N ;
Rio, B ;
Vernant, JP ;
Dib, M ;
Garban, F ;
Cahn, JY ;
Jouet, JP ;
Facon, T .
BLOOD, 2003, 102 (11) :456B-456B
[48]   The Italian experience on interferon as maintenance treatment in multiple myeloma: Ten years after [J].
Pulsoni, A ;
Avvisati, G ;
Mandelli, F ;
Giannarelli, D ;
Lauta, VM ;
Tribalto, M ;
Pileri, A .
BLOOD, 1998, 92 (06) :2184-2186
[49]   Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients [J].
Martino, Massimo ;
Console, Giuseppe ;
Callea, Vincenzo ;
Stelitano, Caterina ;
Massara, Elisabetta ;
Irrera, Giuseppe ;
Messina, Giuseppe ;
Morabito, Fortunato ;
Iacopino, Pasquale .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (01) :35-40
[50]   Thalidomide at very low dosage may represent an effective therapy in relapsed and refractory multiple myeloma. [J].
Guglielmelli, T ;
Capella, S ;
Mattioli, G ;
Guerrasio, A ;
Saglio, G .
BLOOD, 2003, 102 (11) :383B-383B